KORU Medical Systems, Inc. (KRMD) key performance indicators and operating metrics (8 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Diluted Earnings per Share (Non-GAAP) | 0.00 USD_per_share | FY2026-Q1 |
| Domestic Core Net Revenue | 7.7M | FY2026-Q1 |
| International Core Net Revenue | 3.3M | FY2026-Q1 |
| Patient Services and Clinical Trials Net Revenue | 700K | FY2026-Q1 |
| Cash Usage (Net Cash Used) | 100K | FY2026-Q1 |
| Net Operating Loss | -864.92K | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 500K | FY2025-Q4 |
| Core Business Net Revenue | 9.8M | FY2025-Q3 |
Back to KRMD overview · KRMD earnings · KRMD holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.